An international team led by computational biologist Fran Supek at IRB Barcelona develop a machine learning method to predict unknown gene functions of microbes.
The system examines and compares ‘big data’ available on the metagenomes of human and environmental microbiomes.
Researchers at the Centre for Genomic Regulation (CRG) in collaboration with IRB Barcelona, developed a new method to systematically identify genes contributing to heritable cancer risk.
The study, published in Nature Communications, is a success story for data sharing and openness in science.
The Biocat website has dedicated a report to three of the researchers most recently awarded a European Research Council (ERC) Grant. Among them is Fran Supek, leader of the Genome Data Science group at IRB Barcelona, who obtained an ERC Starting Grant to undertake a study on hypermutated tumours.
Link to Biocat
Part of the European Research Council’s reasoning for providing their coveted Starting Grants is to “provide top talent with good conditions at the right time to thrive.” For the team led by Fran Supek (b. Zagreb, Croatia, 1981), the right time has just arrived with the award of a Starting Grant worth 1.5 million euros of funding. His project, called HYPER-INSIGHT, was among the 13% of successful proposals of the 3,085 applications made to the 2017 ‘Starting Grants’ Call.
JutarnjiLife, among other media from Croatia and Bosnia Herzegovina, has dedicated a space to Fran Supek, on the occasion of his receiving a Starting Grant from the European Research Council (ERC).
With this award, the ERC allows high-level scientists such as Supek to work long-term, “leading to important discoveries”. In this case, the research will focus on the genomes of hypermutated tumours.
Link to JutarnjiLife (Croatia)
Link to ...
Diario Médico has echoed that Fran Supek, head of the IRB Barcelona Genome Data Science group, has been awarded a Starting Grant from the European Research Council (ERC). This funding will be used to further his project. Supek aims to acquire greater knowledge of cancer biology in order to support the design of individualised therapies. To this end, he will analyse hypermutated tumours.
Link to Diario Médico
ERC Starting Grants support young talented researchers over 5 years.
The IRB Barcelona group leader will focus on the genomes of hypermutated tumours to detect cancer vulnerabilities.
The magazines "GEN" & "Front Line Genomics" have echoed on the study performed by IRB Barcelona group leader Fran Supek and Ben Lehner at the Centre for Genomic Regulation (CRG) in Barcelona.
Published in the journal Cell, the study identifies one of the key mechanisms responsible for mutations caused by a defective DNA ‘spellchecker’—a process that repairs damage in our genomes.
Link to GEN
Link to Front Line Genomics
IRB Barcelona scientist Fran Supek speaks with the Catalan radio programme "Versió RAC1" about his study he did while working at the CRG, published in Cell. The study identifies errors made by the 'DNA spellchecker’ as an important cause of cancer.
Read the news and listen to Fran Supek in RAC1